TSHA
Taysha Gene TherapiesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
TSHA vs peer average
51/100
TSHA vs. peer average (C vs. C)
Grade spread
B 5 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
SRPT is the first available peer comparator.
Sarepta — large, advanced programs in genetic neuromuscular disease; comparable clinical and commercial risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TSHA
Taysha Gene Therapies
SRPT
Sarepta Therapeutics
Grade
C
C
Momentum
18
86
Value
41
51
Sentiment
64
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs SRPT
TSHA / SRPT
Grade Position
In line
TSHA vs. peer average (C vs. C)
51/100
Momentum
18
SRPTValue
41
SRPTSentiment
64
TSHARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TSHA
SRPT is the first peer returned for this comparison set.